Managing Patients on GLP-1 Medications in Rehabilitation (Recorded Webinar)
Presented by Anna DeLaRosby, Julie Mulcahy, and Todd Norwood
12-Month Subscription
Unlimited access to:
- Thousands of CE Courses
- Patient Education
- Home Exercise Program
- And more
With the increasing prevalence of GLP-1 medications prescribed for obesity and diabetes management, rehabilitation professionals face unique challenges in addressing the implications of these treatments on patient care. GLP-1 receptor agonists impact muscle mass, caloric balance, and metabolic functions, presenting distinct considerations for exercise, injury prevention, and long-term health outcomes. This webinar equips learners with the knowledge and strategies to optimize rehabilitation for patients using GLP-1 medications. Participants will learn to implement tailored exercise programs, screen for potential side effects, and manage associated risks in diverse clinical settings, including outpatient clinics, skilled nursing facilities, and home health environments. This webinar provides actionable insights to ensure safe and effective care for this growing patient population.
Learning Objectives
- Determine the prevalence of GLP-1 use in the clinician’s practice population, and appreciate the role GLP-1 medications play in managing obesity and obesity-related conditions.
- Distinguish the specific challenges that GLP-1 medications present in rehabilitation due to side effects, including caloric deficit, gastrointestinal issues, loss of muscle mass, challenges of medication discontinuation, glycemic control, and weight regain.
- Implement comprehensive screening and examination strategies to identify health risks and mitigate the potential effects of their health history on rehabilitation.
- Construct personalized treatment plans that emphasize muscle mass preservation through physical activity, health management, and the implementation of lifestyle behavior modifications using principles of behavior change.
- Analyze the current research and considerations around the effects of GLP-1 medications and the implications for rehabilitation practices.
Meet your instructors
Anna DeLaRosby
Anna has been a physical therapist since receiving her doctorate in physical therapy in 2008 and loves all things PT. Anna became certified in mechanical diagnosis and therapy in 2012, and in 2014, she became a board-certified orthopedic clinical specialist. Anna is the clinical program manager for Physera Physical Therapy…
Julie Mulcahy
Julie Mulcahy received her doctorate in physical therapy from the University of Michigan. For the past 20+ years, she has specialized in orthopedics, sports medicine, and women’s health. She obtained her Certificate of Achievement in Pregnancy and Postpartum Physical Therapy (CAPP-OB) in 2021 and her LAMP Institute for…
Todd Norwood
Todd received his doctorate in physical therapy from the University of Southern California and his BA in human biology from Stanford University. He is a board-certified clinical specialist in both orthopedic physical therapy and sports physical therapy and is a fellow of the American College of Healthcare Executives. Todd is…
Chapters & learning objectives
1. Prevalence of Diabetes, Obesity, and GLP-1 Use
In this chapter, we’ll determine the prevalence of GLP-1 use in your practice population and appreciate the role GLP-1 medications play in managing obesity and obesity-related conditions.
2. The Role of Rehab Professionals in Managing Obesity and Related Conditions
In this chapter, we’ll distinguish the specific challenges that GLP-1 medications present in rehabilitation due to side effects, including caloric deficit, gastrointestinal issues, loss of muscle mass, challenges of medication discontinuation, glycemic control, and weight regain.
3. Challenges Induced by GLP-1 Medications
In this chapter, we’ll implement comprehensive screening and examination strategies to identify health risks and mitigate the potential effects of their health history on rehabilitation.
4. Management Strategies for Rehab Professionals
In this chapter, we’ll construct personalized treatment plans that emphasize muscle mass preservation through resistance training, appropriate protein and nutrient intake, and the implementation of lifestyle behavior modifications using principles of behavior change.
5. Watch Point/Conclusion
In this chapter, we’ll analyze the current research and considerations around the effects of GLP-1 medications implications for rehabilitation practices.
6. Question and Answer Session
In this chapter, we’ll review and answer the questions asked during the webinar.